UK's CMA Says Portman Healthcare-Dentex Healthcare Deal Raises Competition Concerns

Nov 23 (Reuters) - Alliance Pharma PLC: * UPDATE ON Q4 TRADING * SEES REVENUES FOR YEAR ENDING 31 DECEMBER 2022 WILL BE AT LEAST £170M * SEES FY UNDERLYING PROFIT BEFORE TAX OF AT LEAST £30M Source

Nov 23 (Reuters) - Genus PLC: * GENUS - GROUP'S PROFIT BEFORE TAX IS CURRENTLY ANTICIPATED TO BE IN LINE WITH BOARD'S EXPECTATIONS FOR FINANCIAL YEAR 2023 Source text for Eikon: Further company

Nov 23 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times A potential

(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Best Buy up, sees smaller annual sales drop * Dollar Tree drops on lower FY profit forecast *

Nov 22 (Reuters) - G Medical Innovations Holdings Ltd : * G MEDICAL INNOVATIONS HOLDINGS LTD. ANNOUNCES RECEIPT OF NOTICE OF DEFICIENCY WITH NASDAQ CONTINUED LISTING REQUIREMENTS Source text for Eikon

By Brendan Pierson (Reuters) - The sprawling, five-year-long litigation over the U.S. opioid crisis appears to be entering its final phase with finalized agreements by Teva Pharmaceutical Industries

Nov 22 (Reuters) - Arecor Therapeutics PLC: * ARECOR TO COMMENCE SECOND TRIAL WITH AT278 * TO START SECOND CLINICAL TRIAL WITH AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN CANDIDATE FOR TYPE 2

Nov 22 (Reuters) - Oxford BioMedica PLC: * OXFORD BIOMEDICA APPOINTS FRANK MATHIAS AS CEO * NAMES FRANK MATHIAS AS CHIEF EXECUTIVE OFFICER (CEO) AND BOARD DIRECTOR, EFFECTIVE MARCH 2023 * ROCH

(Adds news items, updates futures) Nov 22 - Britain's FTSE 100 index is seen opening higher on Tuesday with futures up 0.25%. * GSK: GSK Plc has initiated a process to withdraw the U.S. approval for

Nov 22 (Reuters) - Assura PLC: * HY IFRS PROFIT BEFORE TAX £30.9 MILLION (2021: £69.3 MILLION) Source text for Eikon: Further company coverage: